Biologics for Children and Adolescents with Asthma: A Systematic Review and Exploratory Indirect Comparative Analysis.

Xolair (omalizumab) - Roche, Novartis

Nucala (mepolizumab) - GSK

Dupixent (dupilumab) - Sanofi, Regeneron

http://www.ncbi.nlm.nih.gov/pubmed/42741706

Chao Wang; Haoyuan Li; He Geng; Lili Zhi; Ling Zhou; Mengwei Wu; Na Liu; Peize Liu; Xu Li

Sep 16, 2026